Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist

Kazuo Eiho, Hiroyuki Matsui, Hideyuki Hayashi, Ryosaku Inagaki, Mikio Aoki, Mark Biffen, Andrew Leishman, Susan Edwards, Clare Murray, Haruo Takaku, Hideyuki Tomizawa, Shizuo Akira, Yutaka Ueda
European Respiratory Journal 2011 38: p1842; DOI:
Kazuo Eiho
1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Matsui
1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideyuki Hayashi
1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryosaku Inagaki
1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikio Aoki
1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Biffen
2Bioscience, AstraZeneca R&D Charnwood, Loughborough, Leicestershire, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Leishman
2Bioscience, AstraZeneca R&D Charnwood, Loughborough, Leicestershire, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Edwards
2Bioscience, AstraZeneca R&D Charnwood, Loughborough, Leicestershire, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Murray
2Bioscience, AstraZeneca R&D Charnwood, Loughborough, Leicestershire, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haruo Takaku
1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideyuki Tomizawa
1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shizuo Akira
3Laboratory of Host Defense, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yutaka Ueda
1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 38 no. Suppl 55

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online September 27, 2022.

Copyright & Usage 
© 2011 ERS

Author Information

  1. Kazuo Eiho1,
  2. Hiroyuki Matsui1,
  3. Hideyuki Hayashi1,
  4. Ryosaku Inagaki1,
  5. Mikio Aoki1,
  6. Mark Biffen2,
  7. Andrew Leishman2,
  8. Susan Edwards2,
  9. Clare Murray2,
  10. Haruo Takaku1,
  11. Hideyuki Tomizawa1,
  12. Shizuo Akira3 and
  13. Yutaka Ueda1
  1. 1Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan
  2. 2Bioscience, AstraZeneca R&D Charnwood, Loughborough, Leicestershire, United Kingdom
  3. 3Laboratory of Host Defense, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan

Article usage

Article usage: January 2014 to March 2023

AbstractFullPdf
Jan 2014100
Feb 2014100
Mar 2014100
Apr 2014200
May 2014100
Jun 2014100
Aug 2014200
Sep 2014400
Oct 2014200
Nov 2014100
Dec 2014100
Jan 2015500
Feb 2015200
Mar 2015200
Apr 2015500
May 2015300
Jun 2015200
Jul 2015100
Aug 2015600
Sep 20151000
Oct 2015600
Nov 2015400
Dec 2015100
Jan 2016100
Feb 20161200
Mar 2016100
Apr 2016300
May 2016300
Jun 2016300
Aug 2016300
Sep 20161100
Oct 2016200
Nov 2016400
Dec 2016900
Jan 2017700
Feb 2017700
Mar 2017500
Apr 2017500
May 2017500
Jun 2017700
Jul 2017600
Aug 2017900
Sep 2017600
Oct 2017400
Dec 2017500
Jan 2018100
Mar 2018100
Apr 2018200
May 2018700
Jun 2018400
Jul 2018300
Aug 2018600
Sep 2018700
Oct 2018400
Nov 20181300
Dec 2018200
Jan 2019200
Feb 2019300
Mar 2019400
Apr 2019600
Jun 2019100
Jul 2019300
Aug 2019300
Sep 2019100
Oct 2019400
Nov 2019300
Dec 2019100
Jan 2020200
Feb 2020100
Mar 2020900
Apr 2020800
Jun 2020100
Jul 2020100
Aug 20201700
Sep 20201000
Oct 2020600
Nov 2020200
Dec 2020500
Jan 2021100
Feb 2021600
Mar 2021400
Apr 2021300
May 20211300
Jun 20211400
Jul 20215000
Aug 20211000
Sep 2021400
Oct 2021300
Nov 20211500
Dec 20211400
Jan 20222000
Feb 2022400
Mar 2022200
Apr 2022700
May 2022100
Jun 2022500
Jul 20221100
Aug 2022200
Sep 2022200
Oct 2022200
Nov 2022100
Dec 2022300
Feb 2023100

Altmetrics

Previous
Back to top
Vol 38 Issue Suppl 55 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist
Kazuo Eiho, Hiroyuki Matsui, Hideyuki Hayashi, Ryosaku Inagaki, Mikio Aoki, Mark Biffen, Andrew Leishman, Susan Edwards, Clare Murray, Haruo Takaku, Hideyuki Tomizawa, Shizuo Akira, Yutaka Ueda
European Respiratory Journal Sep 2011, 38 (Suppl 55) p1842;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist
Kazuo Eiho, Hiroyuki Matsui, Hideyuki Hayashi, Ryosaku Inagaki, Mikio Aoki, Mark Biffen, Andrew Leishman, Susan Edwards, Clare Murray, Haruo Takaku, Hideyuki Tomizawa, Shizuo Akira, Yutaka Ueda
European Respiratory Journal Sep 2011, 38 (Suppl 55) p1842;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis
  • Farm dust decreases Th2 driven allergic airway inflammation in mice: A role for airway TLR2 and TLR4?
Show more 226. T-cell subsets

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society